GLP1R and type 2 diabetes mellitus: Despite their proven cardiovascular benefit in T2D, the role of GLP-1 RAs in heart failure management, particularly among non-diabetic patients, remains limited, and current guidelines do not recommend them as a first-line option for individuals with established heart failure [7,8].